Authors : Alizamin Sadigov; Malahat Sultanova; Emil Gasimov; Gunel Sadigova; Sharaf Huseynova; Cavid Pashayev

Volume/Issue : Volume 7 - 2022, Issue 7 - July

Google Scholar : https://bit.ly/3IIfn9N

Scribd : https://bit.ly/3dt5geN

DOI : https://doi.org/10.5281/zenodo.6987842

Abstract : Acute respiratory distress syndrome (ARDS) is one of the common clinical manifestation of severe COVID 19 and it is also responsible for the high ventilators demand in worldwide. Our study aims to assess the risk factors predicting mortality in patients with ARDS developing as complication of severe COVID -19. Wecollected clinical data of 289 COVID- 19 related to ARDS patients from 4 hospitals in Baku city, Azerbaijan. The clinical characteristics of the survivors ARDS group and non-survivors ARDS group of COVID19 patients were clinically, laboratory and radiographically compared. Results indicated that the median age ofnonsurvivors ARDS patients was 68.4 years old, which was significantly older than those with survivors ARDS by 9,9 years . Male and patients with BMI>30 were more likely to die from ARDS. The prevalence of consolidation ( consolidation\ground glass opacities ratio>1) in lung , secondary bacterial infection , mechanical ventilation and packof use dexamethasone before intubation were common among non-survivors ARDS.